🔊#D2RProjectSpotlight: From #RNA to personalized #lungdisease treatment
🧬Led by David Langlais (@mcgill.ca), this project aims to identify blood markers for earlier diagnosis and personalized treatment of interstitial lung disease (ILD).
🔗https://shorturl.at/yXxOO
#RNA #RNAtherapies
🎉 Congratulations to the RNAmed doctoral program on securing continued funding from the Elite Network of Bavaria until 2030!
A fantastic achievement for all researchers involved, who are driving forward innovative #RNAtherapies while building strong international collaborations. 🌍🔬
🎓 We're hiring 2 EDI interns for D2R for Fall 2025!
🕒 12 weeks | 10 hrs/week
💰 $2,500 award
📍 Open to @mcgill.ca students (all faculties)
✍ Apply by July 4: mcgill.ca/equity-ethic...
📧 studentadmin.ihsp@mcgill.ca
#RNAtherapies #Equity #Diversity #Inclusion #internship
Anastasia Khvorova, PhD, named 2025 Else Kröner Fresenius Prize for Medical Research awardee for her pioneering work in the field of RNA-based therapies: direc.to/nacK
#EKFprize25 #EKFS #ElseKrönerFreseniusStiftung #RNA #RNAtherapies @ekfstiftung.bsky.social @rti-umasschan.bsky.social
Per la prima volta nella storia, una bambina con #SMA è stata trattata con successo prima della nascita, grazie a una terapia somministrata alla madre.
I risultati sono stati pubblicati sul The New England Journal of Medicine.
#RNAtherapies #ASO
👩🎓👨🎓 A highlight of #D2RSymposium2025 is student trainees presenting D2R projects through poster presentations. Inspiring to see the next generation of researchers contributing to the conversation on #RNAtherapies!
View the list of poster presentations: www.mcgill.ca/dna-to-rna/c...
